Updated October 20 at 4:20pm
Health Care
906 results total, viewing 541 - 550
Westbay Community Action Inc. recently was awarded a $200,000 two-year grant from the National WIC Association to address nutrition needs of children under five, as well as pregnant women and mothers in Kent County. more
Deadlines are approaching for nonprofits to apply for $1.6 million in grants for medical research and community health from the Rhode Island Foundation. more
For the third time in nine years, a team from the University of Rhode Island College of Pharmacy won the 12th annual New England Pharmacy Convention’s Pepto Bowl competition, the university reported. more
CVS Health Corp.’s drug-benefits unit will cover Amgen Inc.’s new cholesterol-cutting injections while excluding a competing treatment from Sanofi and Regeneron Pharmaceuticals Inc., pushing for savings from medications that list for more than $14,000 a year. more
It wasn’t an easy reach, but the R.I. Department of Health recently reported that all health care providers authorized to prescribe opioids and other potent pain medications are now enrolled in the state’s Prescription Drug Monitoring Program. more
Rhode Island College will hold a grand opening and ribbon cutting ceremony for its new School of Nursing wing at the John E. Fogarty Life Science Building on Oct. 7. more
Harbor Lights, a dining and event venue on Warwick Neck, announced it will host the first annual Fall Wine & Craft Beer Tasting to benefit its October charity partner, Gloria Gemma Breast Cancer Resource Foundation. more
The Rhode Island chapter of the American Cancer Society’s Cancer Action Network will host its third annual breakfast meeting on Oct. 14 to convene thought leaders, medical professionals and cancer survivors from across the state to address the need for increased funding of cancer research. more
Butler Hospital recently launched a partial hospital program for young people aged 18 to 26. more
Amgen Inc.’s therapy for a deadly form of skin cancer was approved by U.S. regulators, letting the drugmaker move forward even after a lackluster clinical trial. more
« Prev | 1 52 | 53 | 54 | 55 | 56 | 57 | 58 91 | Next »